Abstract
A compelling body of evidence has demonstrated that gastric cancer has a very particular tumor microenvironment, a signature very suitable to promote tumor progression and metastasis. Recent investigations have provided new insights into the multiple molecular mechanisms, defined by genetic and epigenetic mechanisms, supporting a very active cross talk between the components of the tumor microenvironment and thus defining the fate of tumor progression. In this review, we intend to highlight the roleĀ of very active contributors at gastric cancer TME, particularly cancer-associated fibroblasts, bone marrow-derived cells, tumor-associated macrophages, and tumor-infiltrating neutrophils, all of them surrounded by an overtime changing extracellular matrix. In addition, the very active cross talk between the components of the tumor microenvironment, defined by genetic and epigenetic mechanisms, thus defining the fate of tumor progression, is also reviewed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H (2016) Gastric cancer. Lancet 388:2654ā2664. https://doi.org/10.1016/S0140-6736(16)30354-3.
Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980ā2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 2014;50(7):1330ā1344.
Working Group on the Evaluation of Carcinogenic Risks to Humans. H. pylori Schistosomes, Liver flukes, and H. pylori views and expert opinions of an IARC Working Group On The Evaluation of Carcinogenic Risks To Humans 1994, Lyon, IARC, pp 177ā240
Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global prevalence of H. pylori infection: systematic review and meta-analysis. Gastroenterology 153(2):420ā429
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784ā789
Munn LL (2016) Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med 9(2). https://doi.org/10.1002/wsbm.1370
Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W (2007) Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67:14ā21
Herszenyi L, Miheller P, Tulassay Z (2007) Carcinogenesis in inflammatory bowel disease. Dig Dis 25:267ā269
Li Y, Zhang J, Ma H (2014) Chronic inflammation and gallbladder cancer. Cancer Lett 345(2):242ā248
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423ā1437
Reya T, Morrison SJ, Clarke MF (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105ā111
Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306(5701):1568ā1571
Hayakawa Y, Fox JG, Wang TC (2017) The origins of gastric cancer from gastric stem cells: lessons from mouse models. Cell Mol Gastroenterol Hepatol 3(3):331ā338
Li HC, Stoicov C, Rogers AB, Houghton JM (2006) Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12(3):363ā371
Lee HJ, Song IC, Yun HJ, Jo DY, Kim S (2014) CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting. World J Gastroenterol 20(7):1681ā1693
Lee HJ, Jo DY (2012) The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer. Histol Histopathol 27(9):1155ā1161
Kopp HG, Ramos CA, Rafii S (2006) Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of the tumor and ischemic tissue. Curr Opin Hematol 13:175ā181
Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP (2006) VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20(9):1495ā1497
Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64(23):8492ā8495
Maciel TT, Moura IC, Hermine O (2015) The role of mast cells in cancers, F1000. Prime Rep 7:9
Molin D, Edstrom A, Glimelius I, Glimelius B, Nilsson G, Sundstrom C, Enblad G (2002) Mast cell infiltration correlates with poor prognosis in Hodgkinās lymphoma. Br J Haematol 119(1):122ā124
Ribatti D, Guidolin D, Marzullo A, Nico B, Annese T, Benagiano V, Crivellato E (2010) Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol 91(4):350ā356
Zhong B, Li Y, Liu X, Wang D (2017) Association of mast cell infiltration with gastric cancer progression. Oncol Lett 15(1):755ā764
Lv Y, Zhao Y, Wang X, Chen N, Mao F, Teng Y, Wang T, Peng L, Zhang J, Cheng P, Liu Y, Kong H, Chen W, Hao C, Han B, Ma Q, Zou Q, Chen J, Zhuang Y (2019) Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Ī±-PD-L1 pathway. J Immunother Cancer 7(1):54
Ammendola M, Patruno R, Sacco R, Marech I, Sammarco G, ZuccalĆ V, Luposella M, Zizzo N, Gadaleta C, Porcelli M, Gadaleta CD, Ribatti D, Ranieri G (2016) Mast cells positive to tryptase and tumor-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone surgery. Expert Opin Ther Targets 20(5):533ā540
Liu J, Zhang Y, Zhao J, Yang Z, Li D, Katirai F, Huang B (2011) Mast cell: insight into remodeling a tumor microenvironment. Cancer Metastasis Rev 30(2):177ā184
Liu X, Jin H, Zhang G, Lin X, Chen C, Sun J, Zhang Y, Zhang Q, Yu J (2014) Intratumor IL-17 positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PLoS One 9(9):e106834
Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H (2011) Tumor-infiltrating CD4+ Th17 cells produce IL-17 in the tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 25(5):1271ā1277
Kennedy CL, Najdovska M, Jones GW, McLeod L, Hughes NR, Allison C, Ooi CH, Tan P, Ferrero RL, Jones SA, Dev A, Sievert W, Bhathal PS, Jenkins BJ (2011) The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17. J Pathol 225(2):255ā264
Yang B, Kang H, Fung A, Zhao H, Wang T, Ma D The role of interleukin 17 in tumor proliferation, angiogenesis, and metastasis. Mediators Inflamm 2014, 2014:623759
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101(7):2620ā2627
Ribatti D, Ranieri G (2015) Tryptase, a novel angiogenic factor stored in mast cell granules. Exp Cell Res 332(2):157ā162
de Souza Junior DA, Santana AC, da Silva EZ, Oliver C, Jamur MC (2015) The role of mast cell-specific chymases and tryptases in tumor angiogenesis. Biomed Res In 2015:142359
de Souza DA Jr, Toso VD, Campos MR, Lara VS, Oliver C, Jamur MC (2012) Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS One 7(7):e40790
Sazeides C, Le A (2018) Metabolic relationship between cancer-associated fibroblasts and cancer cells. Adv Exp Med Biol 1063:149ā165
Yan Y, Wang LF, Wang RF (2015) Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer. World J Gastroenterol 21(33):9717ā9726
Yashiro M, Hirakawa K (2010) Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 3:127ā135
Tang D, Gao J, Wang S, Ye N, Chong Y, Huang Y, Wang J, Li B, Yin W, Wang D (2016) Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tumour Biol 37(2):1889ā1899
Kwa MQ, Herum KM, Brakebusch C (2019) Cancer-associated fibroblasts: how do they contribute to metastasis? Clin Exp Metastasis. https://doi.org/10.1007/s10585-019-09959-0
Mishra P, Banerjee D, Ben-Baruch A (2011) Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 89(1):31ā39
Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z, Liu B, Su L (2017) IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget 8(13):20741ā20750
Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K (2018) Fibroblasts in the tumor microenvironment: shield or spear? Int J Mol Sci 19(5):1532
Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173(6):3844ā3854
Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S, Chiarugi P (2014) Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene 33:2423ā2431
Harper J, Sainson RC (2014) Regulation of the anti-tumor immune response by cancer-associated fibroblasts. Semin Cancer Biol 25:69ā77
Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315ā322
Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065ā1073
Prenen H, Mazzone M (2019) Tumor-associated macrophages: a short compendium. Cell Mol Life Sci. https://doi.org/10.1007/s00018-018-2997-3
Pollard JW (2004) Tumor-educated macrophages promote tumor progression and metastasis. Nat Rev Cancer 4:71ā78
Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303ā7311
Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, Krebs W, Sommer D, Sander J, Mertens C, Nino-Castro A, Schmidt SV, Schultze JL (2012) High-resolution transcriptome of human macrophages. PLoS One 7(9):e45466
Rojas A, Delgado-LĆ³pez F, Perez-Castro R, Gonzalez I, Romero J, Rojas I, Araya P, AƱazco C, Morales E, Llanos J (2016) HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biol 37(3):3321ā3329
Rojas A, AƱazco C, Araya P (2017) M2 macrophages do not fly into a āRAGEā. Inflamm Res 66(1):13ā15
Rojas A, Araya P, Romero J, Delgado-LĆ³pez F, Gonzalez I, AƱazco C, Perez-Castro R (2018) Skewed signaling through the receptor for advanced glycation end-products alters the proinflammatory profile of tumor-associated macrophages. Cancer Microenviron 11(2-3):97ā105
Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Miyazono F, Hokita S, Aikou T (2003) Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 23(5A):4079ā4083
Wang XL, Jiang JT, Wu CP (2016) Prognostic significance of tumor-associated macrophage infiltration in gastric cancer: a meta-analysis. Genet Mol Res 15(4). https://doi.org/10.4238/gmr15049040
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu HY, Wang JS, Duan XY (2016) High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial-mesenchymal transition in gastric cancer. Onco Targets Ther 9:3975ā3983
RƤihƤ MR, Puolakkainen PA (2018) Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: a review. Chronic Dis Transl Med 4(3):156ā163
Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, Stolz DB, Land SR, Marconcini LA, Kliment CR, Jenkins KM, Beaulieu KA, Mouded M, Frank SJ, Wong KK, Shapiro SD (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16(2):219ā223
Antonio N, Bonnelykke-Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T, Schmidt H, Feng Y, Martin P (2015) The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J 34(17):2219ā2236
Wculek SK, Malanchi I (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528:413ā417
El Rayes T, Catena R, Lee S, Stawowczyk M, Joshi N, Fischbach C, Powell CA, Dannenberg AJ, Altorki NK, Gao D, Mittal V (2015) Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1. Proc Natl Acad Sci U S A 112(52):16000ā16005
Casbon AJ, Reynaud D, Park C, Khuc E, Gan DD, Schepers K, PasseguĆ© E, Werb Z (2015) Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc Natl Acad Sci U S A 112(6):E566āE575
Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, Fan J, Cao Y, Dai Z, Zhou J (2016) Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology 150(7):1646ā1658
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16(3):183ā194
Zhang W, Gu J, Chen J, Zhang P, Ji R, Qian H, Xu W, Zhang X (2017) Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition. Oncol Rep 38(5):2959ā2966
Jiang YX, Yang SW, Li PA, Luo X, Li ZY, Hao YX, Yu PW (2017) The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Oncogene 36(9):1256ā1264
Li S, Cong X, Gao H, Lan X, Li Z, Wang W, Song S, Wang Y, Li C, Zhang H, Xue Y, Zhao Y (2019) Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res 38(1):6
Wang TT, Zhao YL, Peng LS, , Chen N, Chen W, Li YP, Mao FY, Zhang JY, Cheng P, Teng YS, Fu XL, Yu PW, Guo G, Luo P, Zhuang Y, Zou QM (2017) Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut; 66(11):1900ā1911. doi:https://doi.org/10.1136/gutjnl-2016-313075.
Zhang H, Liu H, Shen Z, Lin C, Wang X, Qin J, Qin X, Xu J, Sun Y (2018) Tumor-infiltrating neutrophils are prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Ann Surg 267(2):311ā318
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J. Cell Sci 123:4195ā4200
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3:1ā24
Johansson N, Ahonen M, KƤhƤri VM (2000) Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57(1):5ā15
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52ā67
Shim K, Jung S, Joo Y, Yoo K (2007) Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 42:120ā128
Rojas A, AƱazco C, GonzĆ”lez I, Araya P (2018) Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Carcinogenesis 39(4):515ā521
Åukaszewicz-ZajÄ c M, Szmitkowski M, Litman-Zawadzka A, Mroczko B (2016) Matrix metalloproteinases and their tissue inhibitors in comparison to other inflammatory proteins in gastric cancer (GC). Cancer Invest 34(7):305ā312
Jang M, Koh I, Lee JE, Lim JY, Cheong JH, Kim P (2018) Increased extracellular matrix density disrupts E-cadherin/Ī²-catenin complex in gastric cancer cells. Biomater Sci 6(10):2704ā2713
Chiurillo MA (2015) Role of the Wnt/Ī²-catenin pathway in gastric cancer: An in-depth literature review. World J Exp Med 5(2):84ā102
Yu H, Mouw JK, Weaver VM (2011) Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 21(1):47ā56
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891ā906
Xiao Q, Ge G (2012) Lysyl oxidase, extracellular matrix remodeling, and cancer metastasis. Cancer Microenviron 5(3):261ā273
Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K (2016) Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia. Gastric Cancer 19(2):431ā442
AƱazco C, Delgado-LĆ³pez F, Araya P, GonzĆ”lez I, Morales E, PĆ©rez-Castro R, Romero J, Rojas A (2016) Lysyl oxidase isoforms in gastric cancer. Biomark Med 10(9):987ā998
Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642ā655
Suzuki HI, Katsura A, Matsuyama H, Miyazono K (2015) MicroRNA regulons in the tumor microenvironment. Oncogene 34(24):3085ā3094
Yang L, Liang H, Wang Y, Gao S, Yin K, Liu Z, Zheng X, Li Y, Wang L, Zhang CY, Chen X, Xu G, Zhang W, Zou X (2016) Mi RNA-203 suppresses tumor cell proliferation, migration and invasion by targeting Slug in gastric cancer. Protein Cell 7(5):383ā387
Link A, Schirrmeister W, Langner C, Varbanova M, Bornschein J, Wex T, Malfertheiner P (2015) Differential expression of microRNAs in preneoplastic gastric mucosa. Sci Rep 5:8270
Huang T, Kang W, Zhang B, Wu F, Dong Y, Tong JH, Yang W, Zhou Y, Zhang L, Cheng AS, Yu J, To KF (2016) miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-ĪŗB signaling in gastric carcinogenesis. Mol Cancer 15:9
Yanaka Y, Muramatsu T, Uetake H, Kozaki K, Inazawa J (2015) miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis 36:1363ā1371
Chen S, Wu J, Jiao K, Wu Q, Ma J, Chen D, Kang J, Zhao G, Shi Y, Fan D, Zhao G (2018) microRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer. Cell Death Dis 9(11):1070
Cao Y, Luo Y, Zou J, Ouyang J, Cai Z, Zeng X, Ling H, Zeng T (2019) Autophagy and its role in gastric cancer. Clin Chim Acta 489:10ā20
Johnstone RM (1992) The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol 70(3-4):179ā190
Vlassov AV, Magdaleno S, Setterquist R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820(7):940ā948
Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, Jiang YH, Yang XH, Liu YP (2009) Gastric cancer exosomes promote tumor cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 41(12):875ā880
Fu M, Gu J, Jiang P, Qian H, Xu W, Zhang X (2019) Exosomes in gastric cancer: roles, mechanisms, and applications. Mol Cancer 18(1):41
Kahroba H, Hejazi MS, Samadi N (2019) Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell Mol Life Sci. https://doi.org/10.1007/s00018-019-03035-2
Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE, de Hingh IH (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134(3):622ā628
Chen KB, Chen J, Jin XL, Huang Y, Su QM, Chen L (2018) Exosome-mediated peritoneal dissemination in gastric cancer and its clinical applications. Biomed Rep 8(6):503ā509
Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R, TrĆ¼mper L, Wulf GG (2011) Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A 108(37):15336ā15341
Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR (2003) Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 63(15):4331ā4337
Liu F, Bu Z, Zhao F, Xiao D (2018) Increased T-helper 17 cell differentiation mediated by exosome-mediated microRNA-451 redistribution in gastric cancer infiltrated T cells. Cancer Sci 109:65ā73
Shen Y, Xue C, Li X, Ba L, Gu J, Sun Z, Han Q, Zhao RC (2019) Effects of gastric cancer cell-derived exosomes on the immune regulation of mesenchymal stem cells by the nf-kb signaling pathway. Stem Cells Dev 28(7):464ā476
Houghton J, Wang TC (2005) Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128(6):1567ā1578
Kumari S, Puneet PSB, Yadav SS, Kumar M, Khanna A, Dixit VK, Nath G, Singh S, Narayan G (2016) Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Med Oncol 33(5):40
Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M (2001) Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7(12):4136ā4142
Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY (2004) Role of the interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126:1030ā1043
Pachathundikandi SK, MĆ¼ller A, Backert S (2016) Inflammasome activation by Helicobacter pylori and its implications for persistence and immunity. Curr Top Microbiol Immunol 397:117ā131
Hu Y, Liu JP, Zhu Y, Lu NH (2016) The importance of toll-like receptors in nf-Īŗb signaling pathway activation by Helicobacter pylori infection and the regulators of this response. Helicobacter 21(5):428ā440
Rojas A, GonzĆ”lez I, RodrĆguez B, Romero J, Figueroa H, Llanos J, Morales E, PĆ©rez-Castro R (2011) Evidence of involvement of the receptor for advanced glycation end-products (RAGE) in the adhesion of Helicobacter pylori to gastric epithelial cells. Microbes Infect 13(10):818ā823
Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC, Li AF, Wang AM, Kuo ML, Chi CW (2009) The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res 69(12):5039ā5048
Xiao C, Ogle SA, Schumacher MA, Orr-Asman MA, Miller ML, Lertkowit N, Varro A, Hollande F, Zavros Y (2010) Loss of parietal cell expression of sonic hedgehog induces hypergastrinemia and hyperproliferation of surface mucous cells. Gastroenterology 138:550ā556
Lee SY, Han HS, Lee KY, Hwang TS, Kim JH, Sung IK, Park HS, Jin CJ, Choi KW (2007) Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncol Rep 17(5):1051ā1055
Wang LH, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, Yun HY, Park SM, Kim WJ, Kim HJ, Choi JS, Kim SH (2006) Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 19(5):675ā683
Schumacher MA, Feng R, Aihara E, Engevik AC, Montrose MH, Ottemann KM, Zavros Y (2015) Helicobacter pylori-induced Sonic Hedgehog expression is regulated by NFĪŗB pathway activation: the use of a novel in vitro model to study epithelial response to infection. Helicobacter 20(1):19ā28
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127(3):469ā480
Cai C, Zhu X (2012) The Wnt/Ī²-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Mol Med Rep 5:1191ā1196
Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A (2012) An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer Ther 11(2):298ā307
Song X, Xin N, Wang W, Zhao C (2015) Wnt/Ī²-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Oncotarget 6(34):35579ā35588
Zhou GX, Li XY, Zhang Q, Zhao K, Zhang CP, Xue CH, Yang K, Tian ZB (2013) Effects of the Hippo signaling pathway in human gastric cancer. Asian Pac J Cancer Prev 14(9):5199ā5205
Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA, Sakuma R, Pawson T, Hunziker W, McNeill H, Wrana JL, Attisano L (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18(4):579ā591
Chen HJ, Wang CM, Wang TW, Liaw GJ, Hsu TH, Lin TH, Yu JY (2011) The Hippo pathway controls polar cell fate through Notch signaling during Drosophila oogenesis. Dev Biol 357(2):370ā379
Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, Hida T, Tsujimura T, Osada H, Sekido Y (2012) TGF-Ī² synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 209(3):479ā494
Katz LH, Li Y, Chen JS, MuƱoz NM, Majumdar A, Chen J, Mishra L (2013) Targeting TGF-Ī² signaling in cancer. Expert Opin Ther Targets 17(7):743ā760
David CJ, Massague J (2018) Contextual determinants of TGF-beta action in development, immunity, and cancer. Nat Rev Mol Cell Biol 19(7):419ā435
Leng A, Liu T, He Y, Li Q, Zhang G (2009) Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer. Exp Mol Pathol 87(1):48ā53
Ma H, Gao L, Li S, Qin J, Chen L, Liu X, Xu P, Wang F, Xiao H, Zhou S (2015) CCR7 enhances TGF-beta1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer. Oncotarget 6(27):24348ā24360
Ouyang S, Zhu G, Ouyang L, Luo Y, Zhou R, Pan C, Bin J, Liao Y, Liao W (2017) Bapx1 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition and promotes a malignancy phenotype of gastric cancer cells. Biochem Biophys Res Commun 486(2):285ā292
Wieduwilt MJ, Moasser MM (2008) The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 65(10):1566ā1584
Holbro T, Hynes NE (2004) ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195ā217
Abhold EL, Kiang A, Rahimy E, Kuo SZ, Wang-Rodriguez J, Lopez JP, Blair KJ, Yu MA, Haas M, Brumund KT, Altuna X, Patel A, Weisman RA, Ongkeko WM (2012) EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS One 7(2):e32459
Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ (2003) Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growth in the bone of nude mice. Clin Cancer Res 9:1200ā1210
Takahashi M, Nakajima M, Ogata H, Domeki Y, Ohtsuka K, Ihara K, Kurayama E, Yamaguchi S, Sasaki K, Miyachi K, Kato H (2013) CD24 expression is associated with progression of gastric cancer. Hepatogastroenterology 60:653ā658
Wang YC, Wang JL, Kong X, Sun TT, Chen HY, Hong J, Fang JY (2014) CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation. Apoptosis 19:643ā656. https://doi.org/10.1007/s10495-013-0949-9.c
Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH (2007) Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Ann Surg Oncol 14(10):2748ā2758
Deng W, Gu L, Li X, Zheng J, Zhang Y, Duan B, Cui J, Dong J, Du J (2016) CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells. J Transl Med 14:32
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rojas, A., Araya, P., Gonzalez, I., Morales, E. (2020). Gastric Tumor Microenvironment. In: Birbrair, A. (eds) Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology, vol 1226. Springer, Cham. https://doi.org/10.1007/978-3-030-36214-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-36214-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36213-3
Online ISBN: 978-3-030-36214-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)